| Drug targets for corona virus: A systematic review M Prajapat, P Sarma, N Shekhar, P Avti, S Sinha, H Kaur, S Kumar, ... Indian journal of pharmacology 52 (1), 56-65, 2020 | 550 | 2020 |
| Virological and clinical cure in COVID‐19 patients treated with hydroxychloroquine: a systematic review and meta‐analysis P Sarma, H Kaur, H Kumar, D Mahendru, P Avti, A Bhattacharyya, ... Journal of medical virology 92 (7), 776-785, 2020 | 234 | 2020 |
| In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain) P Sarma, N Shekhar, M Prajapat, P Avti, H Kaur, S Kumar, S Singh, ... Journal of Biomolecular Structure and Dynamics 39 (8), 2724-2732, 2021 | 223 | 2021 |
| Serum ferritin as a predictive biomarker in COVID-19. A systematic review, meta-analysis and meta-regression analysis K Kaushal, H Kaur, P Sarma, A Bhattacharyya, DJ Sharma, M Prajapat, ... Journal of critical care 67, 172-181, 2022 | 155 | 2022 |
| Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach P Sarma, M Prajapat, P Avti, H Kaur, S Kumar, B Medhi Indian journal of pharmacology 52 (1), 1-5, 2020 | 100 | 2020 |
| Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2 M Prajapat, N Shekhar, P Sarma, P Avti, S Singh, H Kaur, ... Journal of Molecular Graphics and Modelling 101, 107716, 2020 | 76 | 2020 |
| Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review A Bhattacharyya, P Sarma, DJ Sharma, KK Das, H Kaur, M Prajapat, ... Indian journal of pharmacology 53 (4), 317-327, 2021 | 68 | 2021 |
| Update on the target structures of SARS-CoV-2: A systematic review M Prajapat, P Sarma, N Shekhar, A Prakash, P Avti, A Bhattacharyya, ... Indian Journal of Pharmacology 52 (2), 142-149, 2020 | 56 | 2020 |
| Clinically relevant cell culture models and their significance in isolation, pathogenesis, vaccine development, repurposing and screening of new drugs for SARS-CoV-2: a … S Kumar, P Sarma, H Kaur, M Prajapat, A Bhattacharyya, P Avti, ... Tissue and Cell 70, 101497, 2021 | 44 | 2021 |
| Ocular manifestations and tear or conjunctival swab PCR positivity for 2019-nCoV in patients with COVID-19: a systematic review and meta-analysis P Sarma, H Kaur, H Kaur, J Bhattacharyya, M Prajapat, N Shekhar, P Avti, ... Available at SSRN 3566161, 2020 | 43 | 2020 |
| COVID-19–associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis A Bhattacharyya, P Sarma, H Kaur, S Kumar, J Bhattacharyya, M Prajapat, ... Indian Journal of Pharmacology 53 (6), 499-510, 2021 | 39 | 2021 |
| Efficacy and safety of dihydroorotate dehydrogenase (DHODH) inhibitors “leflunomide” and “teriflunomide” in Covid-19: A narrative review H Kaur, P Sarma, A Bhattacharyya, S Sharma, N Chhimpa, M Prajapat, ... European journal of pharmacology 906, 174233, 2021 | 31 | 2021 |
| Safety and efficacy of lopinavir/ritonavir combination in COVID-19: A systematic review, meta-analysis, and meta-regression analysis A Bhattacharyya, S Kumar, P Sarma, H Kaur, M Prajapat, N Shekhar, ... Indian journal of pharmacology 52 (4), 313-323, 2020 | 30 | 2020 |
| Efficacy and safety of steroid therapy in COVID-19: A rapid systematic review and Meta-analysis P Sarma, A Bhattacharyya, H Kaur, M Prajapat, A Prakash, S Kumar, ... Indian journal of pharmacology 52 (6), 535-550, 2020 | 29 | 2020 |
| Computational basis of SARS-CoV 2 main protease inhibition: an insight from molecular dynamics simulation based findings P Avti, A Chauhan, N Shekhar, M Prajapat, P Sarma, H Kaur, ... Journal of Biomolecular Structure and Dynamics 40 (19), 8894-8904, 2022 | 24 | 2022 |
| Neuroprotective effect of the standardised extract of Bacopa monnieri (BacoMind) in valproic acid model of autism spectrum disorder in rats M Abhishek, S Rubal, K Rohit, J Rupa, S Phulen, K Gurjeet, SA Raj, ... Journal of ethnopharmacology 293, 115199, 2022 | 23 | 2022 |
| In Silico Structure-Based Repositioning of Approved Drugs for Spike Glycoprotein S2 Domain Fusion Peptide of SARS-CoV-2: Rationale from Molecular Dynamics … N Shekhar, P Sarma, M Prajapat, P Avti, H Kaur, A Raja, H Singh, ... Msystems 5 (5), 10.1128/msystems. 00382-20, 2020 | 21 | 2020 |
| Structural and conformational analysis of SARS CoV 2 N-CTD revealing monomeric and dimeric active sites during the RNA-binding and stabilization: insights towards potential … A Chauhan, P Avti, N Shekhar, M Prajapat, P Sarma, A Bhattacharyya, ... Computers in biology and medicine 134, 104495, 2021 | 20 | 2021 |
| Efficacy of green tea, its polyphenols and nanoformulation in experimental colitis and the role of non-canonical and canonical nuclear factor kappa beta (NF-kB) pathway: a … SB Varthya, P Sarma, A Bhatia, N Shekhar, M Prajapat, H Kaur, ... Journal of Biomolecular Structure and Dynamics 39 (14), 5314-5326, 2021 | 19 | 2021 |
| Bacteriological pattern and their correlation with complications in culture positive cases of acute bacterial conjunctivitis in a tertiary care hospital of upper Assam: A cross … A Bhattacharyya, P Sarma, B Sarma, S Kumar, T Gogoi, H Kaur, ... Medicine 99 (7), e18570, 2020 | 17 | 2020 |
